Table 1 Correlation of miR-19b expression with clinicopathological features of hepatocellular carcinoma
| Â | Â | miR-19b expression | ||
|---|---|---|---|---|
Clinicopathological variables | Number of cases | High | Low | P |
Age | ||||
 > 60 | 33(40.7) | 16(40) | 17(41.5) | 0.893 |
 < 60 | 48(59.3) | 24(60) | 24(58.5) |  |
Gender | ||||
 Male | 55(67.9) | 25(62.5) | 30(73.2) | 0.304 |
 Female | 26(32.1) | 15(37.5) | 11(26.8) |  |
TNM stage | ||||
 II | 58(71.6) | 31(77.5) | 27(65.9) | 0.245 |
 III + IV | 23(28.4) | 9(22.5) | 14(34.1) |  |
Liver cirrhosis | ||||
 Yes | 26(32.1) | 15(37.5) | 11(26.8) | 0.304 |
 No | 55(67.9) | 25(62.5) | 30(73.2) |  |
Vascular invasiona | ||||
 Presence | 62(76.5) | 29(72.5) | 33(80.5) | 0.369 |
 Absence | 19(23.5) | 11(27.5) | 8(19.5) |  |
AFP (ng/ml) | ||||
 > 20 | 48(59.3) | 29(72.5) | 19(46.3) | 0.017 |
 < 20 | 33(40.7) | 11(27.5) | 22(53.7) |  |
Tumor differentiation | ||||
 W + M | 66(81.5) | 32(80) | 34(82.9) | 0.735 |
 P | 15(18.5) | 8(20) | 7(17.1) |  |
Tumor number | ||||
 Solitary | 58(71.6) | 30(75) | 28(68.3) | 0.503 |
 Multiple | 23(28.4) | 10(25) | 13(31.7) |  |